Lv5
1010 积分 2021-11-15 加入
Obinutuzumab in patients with repeated lupus nephritis flares: A case series
9天前
已完结
Effectiveness of Semaglutide in Overweight or Obese Patients With IgA Nephropathy Without Diabetes
15天前
已完结
From Despair to Promise: The Dawn of Novel Treatment in IgA Nephropathy
2个月前
已关闭
Identification of two distinct clusters in membranous lupus nephritis patients: recognition of a high-risk profile based on unsupervised analysis
2个月前
已完结
A ‘two-hit’ model of cystogenesis in autosomal dominant polycystic kidney disease?
2个月前
已完结
Commentary on the 2021 update of the KDIGO clinical practice guideline for management of blood pressure in chronic kidney disease
3个月前
已完结
From Despair to Promise: The Dawn of Novel Treatment in IgA Nephropathy
4个月前
已关闭
Overview of Traditional and Environmental Factors Related to Bone Health
6个月前
已完结
[Expert consensus on the treatment of chronic kidney disease with tuberculosis (2022 version)]
7个月前
已完结
[Chinese expert consensus on the guidance of anti-tumor drugs for patients with tumor combined chronic kidney disease (2024 edition)]
7个月前
已完结
皖公网安备34019202002308
